Abbott Recalls CGM Monitors

Abbott announced that a limited quantity of Freestyle Libre 3 sensors that were supplied in the United States during the first half of May had been recalled.

According to the business, internal testing revealed that a subset of three batches of the continuous glucose monitor (CGM) sensors can give falsely high glucose readings. False measurements may cause patients to receive the wrong medication, such as insulin when it is not necessary.

Abbott is providing impacted consumers with free replacements. When questioned, an Abbott representative declined to say how many devices were impacted, responding instead that the recall “may impact less than 1% of Libre 3 users in the U.S.”

To find out if their devices are impacted, consumers are urged by Abbott to go to www.FreeStyleConfirm.com and input the serial numbers of their sensors. Customers have been advised by the business not to use any of the recalled sensors. Anyone wearing one of the impacted sensors should take it off right now.